Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Audran

Showing results (191-200 of 197) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 197 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 10, 2011
High prevalence of vertebral fractures in women with breast cancer starting aromatase inhibitor therapyB Bouvard, E Hoppé, P Soulié, et al.
The Journal of Clinical Endocrinology and Metabolism|January 24, 2013
Efficacy and safety of strontium ranelate in the treatment of osteoporosis in menJ-M Kaufman, M Audran, G Bianchi, et al.
Calcified Tissue International|August 24, 2000
Do estrogens effectively prevent osteoporosis-related fractures? The Group for the Respect of Ethics and Excellence in ScienceJ Y Reginster, O Bruyere, M Audran, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2014
Fracture incidence after 3 years of aromatase inhibitor therapyB Bouvard, P Soulié, E Hoppé, et al.
Annals of the Rheumatic Diseases|September 27, 2000
Background for studies on the treatment of male osteoporosis: state of the artJ M Kaufman, O Johnell, E Abadie, et al.
Blood Cancer Journal|August 29, 2015
Factors associated with an increased risk of vertebral fracture in monoclonal gammopathies of undetermined significanceJ M Piot, M Royer, A Schmidt-Tanguy, et al.
Calcified Tissue International|November 1, 1996
Recommendations for the registration of agents used in the prevention and treatment of glucocorticoid-induced osteoporosisJ E Compston, M Audran, B Avouac, et al.
Pageof 20

Showing results (191-200 of 197) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 197 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 10, 2011
High prevalence of vertebral fractures in women with breast cancer starting aromatase inhibitor therapyB Bouvard, E Hoppé, P Soulié, et al.
The Journal of Clinical Endocrinology and Metabolism|January 24, 2013
Efficacy and safety of strontium ranelate in the treatment of osteoporosis in menJ-M Kaufman, M Audran, G Bianchi, et al.
Calcified Tissue International|August 24, 2000
Do estrogens effectively prevent osteoporosis-related fractures? The Group for the Respect of Ethics and Excellence in ScienceJ Y Reginster, O Bruyere, M Audran, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2014
Fracture incidence after 3 years of aromatase inhibitor therapyB Bouvard, P Soulié, E Hoppé, et al.
Annals of the Rheumatic Diseases|September 27, 2000
Background for studies on the treatment of male osteoporosis: state of the artJ M Kaufman, O Johnell, E Abadie, et al.
Blood Cancer Journal|August 29, 2015
Factors associated with an increased risk of vertebral fracture in monoclonal gammopathies of undetermined significanceJ M Piot, M Royer, A Schmidt-Tanguy, et al.
Calcified Tissue International|November 1, 1996
Recommendations for the registration of agents used in the prevention and treatment of glucocorticoid-induced osteoporosisJ E Compston, M Audran, B Avouac, et al.
Pageof 20